CIPLA
Back to Balance Sheet
|
CIPLA Last 5 Year Unsecured Loans History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Unsecured Loans | ₹117 Cr | ₹12 Cr | - | ₹-332 Cr | ₹40 Cr |
What is the latest Unsecured Loans ratio of CIPLA ?
| Year | Unsecured Loans |
|---|---|
| Mar2026 | ₹117 Cr |
| Mar2025 | ₹12 Cr |
| Mar2024 | - |
| Mar2023 | ₹-332 Cr |
| Mar2022 | ₹40 Cr |
How is Unsecured Loans of CIPLA Trending?
| Years | Unsecured Loans | % Change | |
|---|---|---|---|
| Mar2026 | ₹117 Cr | 880.55 | |
| Mar2025 | ₹12 Cr | 0 | |
| Mar2024 | - | 100.00 | |
| Mar2023 | ₹-332 Cr | Negative | |
| Mar2022 | ₹40 Cr | - | |
Compare Unsecured Loans of peers of CIPLA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CIPLA | ₹115,222.7 Cr | -0.3% | 2.3% | -8.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,090.0 Cr | 1% | -2.7% | 15.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹226,976.0 Cr | 0.7% | 17.1% | 40.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,639.0 Cr | -0.3% | -3.7% | 37.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,074.4 Cr | -1.4% | 0.7% | -6.2% | Stock Analytics | |
| MANKIND PHARMA | ₹97,962.6 Cr | -1.2% | -7.2% | -3.5% | Stock Analytics | |
CIPLA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CIPLA | -0.3% |
2.3% |
-8.1% |
| SENSEX | -0.6% |
1% |
-3.7% |
You may also like the below Video Courses